Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis. (August 2022)

• Record Type: Journal Article
• Authors: Gatti, Milo; Rinaldi, Matteo; Bussini, Linda; Bonazzetti, Cecilia; Pascale, Renato; Pasquini, Zeno; Faní, Francesca; Pinho Guedes, Mariana Nunes; Azzini, Anna Maria; Carrara, Elena; Palacios-Baena, Zaira R.; Caponcello, Giulia; Reyna-Villasmil, Eduardo; Tacconelli, Evelina; Rodríguez-Baño, Jesús; Viale, Pierluigi; Giannella, Maddalena; Caroccia, Natascia; Arbizzani, Federica; Giacomini, Maria Eugenia; Vatamanu, Oana; Razzaboni, Elisa; De Rui, Maria Elena; Gorska, Anna; Maldonado, Natalia; Olivares, Paula; Gutiérrez-Campos, David; Martín-Gutiérrez, Ana Belén; Palomo, Virginia; Serna, Almudena
• Is Part Of: Clinical microbiology and infection. Volume 28:Number 8(2022)
• Page Start: 1057
• Page End: 1065
• Publication Date: 2022-08
• Subjects: 30-Day mortality rate -- Clinical outcome -- COVID-19 -- Solid organ transplant recipients -- Superinfections; Medical microbiology -- Periodicals; Diagnostic microbiology -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 616.01
• DOI: 10.1016/j.cmi.2022.02.039
• Languages: English
• ISSNs: 1198-743X

Abstract

Abstract: Background: A significant increased risk of complications and mortality in immunocompromised patients affected by COVID-19 has been described. However, the impact of COVID-19 in solid organ transplant (SOT) recipients is an issue still under debate, due to conflicting evidence that has emerged from different observational studies. Objectives: We performed a systematic review with a meta-analysis to assess the clinical outcome in SOT recipients with COVID-19 compared with the general population. Data sources: PubMed-MEDLINE and Scopus were independently searched until 13 October 2021. Study eligibility criteria: Prospective or retrospective observational studies comparing clinical outcome in SOT recipients versus general populations affected by COVID-19 were included. The primary endpoint was 30-day mortality. Participants: Participants were patients with confirmed COVID-19. Interventions: Interventions reviewed were SOTs. Methods: The quality of the included studies was independently assessed with the Risk of Bias in Non-randomized Studies of Interventions tool for observational studies. The meta-analysis was performed by pooling ORs retrieved from studies providing adjustment for confounders using a random-effects model with the inverse variance method. Multiple subgroups and sensitivity analyses were conducted to investigate the source of heterogeneity. Results: A total of 3501 articles were screened, and 31 observational studies ( N = 590 375; 5759 SOT recipients vs. 584 616 general population) were included in the meta-analyses. No difference in 30-day mortality rate was found in the primary analysis, including studies providing adjustment for confounders ( N = 17; 3752 SOT recipients vs. 159 745 general population; OR: 1.13; 95% CI, 0.94–1.35; I 2 = 33.9%). No evidence of publication bias was reported. A higher risk of intensive care unit admission (OR: 1.56; 95% CI, 1.03–2.63) and occurrence of acute kidney injury (OR: 2.50; 95% CI, 1.81–3.45) was found in SOT recipients. Conclusions: No increased risk in mortality was found in SOT recipients affected by COVID-19 compared with the general population when adjusted for demographic and clinical features and COVID-19 severity.